International Journal of Pharmaceutical Medicine

, Volume 21, Issue 6, pp 391–394 | Cite as

Setting Up an Internal Education Programme in Pharmaceutical Medicine

The AstraZeneca ‘MedEd’ Experience
Current Opinion
  • 20 Downloads

Abstract

In 1999 a global medical education function (later called ‘MedEd’) was established with the goal of delivering high quality learning opportunities to AstraZeneca’s physicians and scientists in the form of inhouse courses and seminars, as well as through web-based distance learning programmes.

To maximise the sharing of internal competence and experience, the courses and seminars are directed, staffed and taught primarily by our own professionals. This ‘peer-to-peer’ learning model allows AstraZeneca employees to focus on the most company-specific and relevant information. Participation of our professionals as both faculty and students also encourages informal networking among functions and across the global organisation. The MedEd team has delivered over 80 programmes on four continents to over 4500 participants in AstraZeneca’s research and development organisation and subsidiary marketing companies. In our experience, the teachers, who are usually senior specialists or managers, find the activities as rewarding as the students.

Keywords

Internal Faculty Line Manager Pharmaceutical Medicine Medical Education Programme Pharmaceutical Physician 

Notes

Acknowledgements

The authors are both employees at AstraZeneca. No sources of funding were used to assist in the preparation of this paper.

References

  1. 1.
    Faculty of Pharmaceutical Medicine. History of the Faculty: the history and aims of the Faculty of Pharmaceutical Medicine [online]. Available from URL: http:// www.fpm.org.uk/faculty/history [Accessed 2007 Sep 26]Google Scholar
  2. 2.
    Rondel RK. History [online]. Available from URL:http://www.ifapp.org/pub/ [Accessed 2007 Sep 26]Google Scholar
  3. 3.
    Stonier PD, Silva H, Lahon H. Pharmaceutical medicine: history, global status, evolution and development. Int J Pharm Med 2007; 21 (4): 253–62CrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2007

Authors and Affiliations

  1. 1.AstraZeneca R&DSödertäljeSweden
  2. 2.WilmingtonUSA

Personalised recommendations